Mode
Text Size
Log in / Sign up

Tick-Borne Encephalitis

Part of Flavivirus Infections

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Tick-Borne Encephalitis

5 trials tracked for Tick-Borne Encephalitis: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 17 citations.

5Trials tracked
4Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 1
  1. Phase 4 Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) Completed · 17 cited
  2. Phase 3 Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older Completed · 2 cited
  3. Phase 4 Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules Completed
  4. Phase 3 Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children Completed
  5. Phase 2 Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Flavivirus Infections

Related studies from across the Flavivirus Infections family.